摘要
Periprosthetic joint infections contribute significantly to patient morbidity,prolonged hospital stays,and escalating healthcare costs.Defensive antibacterial coating(DAC®)hydrogel has emerged as a promising strategy to combat these infections.It forms a biodegradable barrier that reduces bacterial adhesion and can deliver local antibiotics,thereby addressing a key mechanism in biofilm formation.Early clinical evidence suggests that DAC®effectively lowers infection recurrence in revision hip and knee arthroplasties,with additional benefits in trauma procedures and soft tissue repairs.Moreover,it has demonstrated compat-ibility with existing implants and surgical techniques,while potentially reducing overall antibiotic use and hospital stays.Despite these encouraging findings,data for its use in primary arthroplasty remains limited,underscoring the need for large-scale,high-quality studies.Future research is poised to refine DAC®’s antimicrobial efficacy through novel antibiotic combinations,personalised delivery systems,and broader applications beyond lower limb procedures.As the prevalence of comorbidities continues to rise,DAC®represents a valuable addi-tion to multifaceted infection control protocols,potentially transforming ortho-paedic care by enhancing patient outcomes and mitigating the economic and clinical burden of implant-related infections.
